6 months treatment with Herceptin is as good as 12 months for preventing breast cancer return

by Peter Thorley,University of WarwickCredit: CC0 Public DomainA new study co-led by the University of Warwick Clinical Trials Unit has shown that shortening the duration of a therapy for breast

Updated on: March 14,2024

6 months treatment with Herceptin is as good as 12 months for preventing breast cancer return

by Peter Thorley,University of WarwickCredit: CC0 Public DomainA new study co-led by the University of Warwick Clinical Trials Unit has shown that shortening the duration of a therapy for breast

Updated on:March 14,2024

Most U.S. children have adequate geographic access to cancer care

by Lori SolomonMost U.S. children and adolescents and young adults (AYAs) have adequate access to pediatric cancer care, according to a study published online Jan. 19 inJAMA Network Open.Xiaohui

Updated on: December 20,2023

Most U.S. children have adequate geographic access to cancer care

by Lori SolomonMost U.S. children and adolescents and young adults (AYAs) have adequate access to pediatric cancer care, according to a study published online Jan. 19 inJAMA Network Open.Xiaohui

Updated on:December 20,2023

Protein transformation drives cancer development

byNorthwestern UniversityMitochondria. Credit: Wikipedia commonsA change in function in a mitochondrial antioxidant protein increases stem cell gene expression that promotes the development of m

Updated on: December 20,2023

Protein transformation drives cancer development

byNorthwestern UniversityMitochondria. Credit: Wikipedia commonsA change in function in a mitochondrial antioxidant protein increases stem cell gene expression that promotes the development of m

Updated on:December 20,2023

Study offers a potential strategy to improve T cell therapy in solid tumors

byPerelman School of Medicine at the University of PennsylvaniaRegnase-1 and Roquin-1 double knockout alters the activation profile of resting engineered T cells. (A) Healthy human donor T cells

Updated on: December 22,2023

Study offers a potential strategy to improve T cell therapy in solid tumors

byPerelman School of Medicine at the University of PennsylvaniaRegnase-1 and Roquin-1 double knockout alters the activation profile of resting engineered T cells. (A) Healthy human donor T cells

Updated on:December 22,2023

Novel combination of antibodies leads to significant improvement in cancer immunotherapy

byUniversity of BaselCredit: CC0 Public DomainThe simultaneous use of antibodies based on two differing mechanisms of action leads to a more effective destruction of tumors. This has been demons

Updated on: December 20,2023

Novel combination of antibodies leads to significant improvement in cancer immunotherapy

byUniversity of BaselCredit: CC0 Public DomainThe simultaneous use of antibodies based on two differing mechanisms of action leads to a more effective destruction of tumors. This has been demons

Updated on:December 20,2023

More women need to be screened for cervical cancer

by Lesley Young,University of AlbertaCredit: CC0 Public DomainUp to 30 per cent of Canadian women are not being regularly screened for cervical cancer, and the lapse is resulting in unnecessary

Updated on: December 18,2023

More women need to be screened for cervical cancer

by Lesley Young,University of AlbertaCredit: CC0 Public DomainUp to 30 per cent of Canadian women are not being regularly screened for cervical cancer, and the lapse is resulting in unnecessary

Updated on:December 18,2023

Public insurance tied to lower cancer survival in young patients

(HealthDay)—Young, low-income patients with bone or soft tissue sarcomas have decreased overall survival (OS), regardless of disease stage at presentation, according to a study published online Dec. 1

Updated on: December 22,2023

Public insurance tied to lower cancer survival in young patients

(HealthDay)—Young, low-income patients with bone or soft tissue sarcomas have decreased overall survival (OS), regardless of disease stage at presentation, according to a study published online Dec. 1

Updated on:December 22,2023

Putting a dollar value on cancer survival

by University of the Sunshine CoastCredit: Pixabay/CC0 Public DomainNew University of the Sunshine Coast-led research has for the first time estimated the health care costs of Queenslanders who surviv

Updated on: February 20,2024

Putting a dollar value on cancer survival

by University of the Sunshine CoastCredit: Pixabay/CC0 Public DomainNew University of the Sunshine Coast-led research has for the first time estimated the health care costs of Queenslanders who surviv

Updated on:February 20,2024

Integrating mental health services into oncology treatment protocols

byThe City University of New YorkStudy participant is interviewed. Credit: The City University of New YorkA new study by CUNY SPH doctoral student Thinh Vu and colleagues reveals that cancer inp

Updated on: December 26,2023

Integrating mental health services into oncology treatment protocols

byThe City University of New YorkStudy participant is interviewed. Credit: The City University of New YorkA new study by CUNY SPH doctoral student Thinh Vu and colleagues reveals that cancer inp

Updated on:December 26,2023

Most cancer patients want access to complementary therapies before treatment

by The Reis GroupCredit: Pixabay/CC0 Public DomainNearly two-thirds (62%) of people with cancer want to know about complementary therapies such as exercise, nutrition counseling, massage, and meditati

Updated on: December 20,2023

Most cancer patients want access to complementary therapies before treatment

by The Reis GroupCredit: Pixabay/CC0 Public DomainNearly two-thirds (62%) of people with cancer want to know about complementary therapies such as exercise, nutrition counseling, massage, and meditati

Updated on:December 20,2023

New research finds oral leukemia therapy to work as well as intravenous decitabine

by Hackensack Meridian HealthCredit: Pixabay/CC0 Public DomainResearchers at Hackensack Meridian's John Theurer Cancer Center (JTCC), are part of a published Phase 3 study reporting on the equival

Updated on: March 21,2024

New research finds oral leukemia therapy to work as well as intravenous decitabine

by Hackensack Meridian HealthCredit: Pixabay/CC0 Public DomainResearchers at Hackensack Meridian's John Theurer Cancer Center (JTCC), are part of a published Phase 3 study reporting on the equival

Updated on:March 21,2024

Epigenetic therapy worth pursuing in hormone receptor positive advanced breast cancer

byEuropean Society for Medical OncologyCredit: CC0 Public DomainEpigenetic therapy with histone deacetylase (HDAC) inhibitors is worth pursuing in hormone receptor positive advanced breast cance

Updated on: December 18,2023

Epigenetic therapy worth pursuing in hormone receptor positive advanced breast cancer

byEuropean Society for Medical OncologyCredit: CC0 Public DomainEpigenetic therapy with histone deacetylase (HDAC) inhibitors is worth pursuing in hormone receptor positive advanced breast cance

Updated on:December 18,2023